Reduced expression of mir15a in the blood of patients with oral squamous cell carcinoma is associated with tumor staging

Experimental and Therapeutic Medicine

Volumn 1, Issue 1, 2010, Pages 217-221

  Brito, João Artur Ricieri ^a   Gomes, Carolina Cavaliéri ^a   Pimenta, Flávio Juliano Garcia Santos ^a   Barbosa, Alvimar Afonso ^b   Prado, Marco Antônio Máximo ^d   Prado, Vânia Ferreira ^d   Gomez, Marcus Vinícius ^c   Gomez, Ricardo Santiago ^a  

^a School of Dentistry   (Brazil)

^b Rua Nestor Barbosa   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Let7a; MicroRNA; Mir15a; Oral cancer

Indexed keywords

LET7A; MICRORNA; MICRORNA 15A; MYC PROTEIN; PROTEIN BCL 2; RAS PROTEIN; UNCLASSIFIED DRUG;

ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

EID: 77955796432     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000035     Document Type: Article

References (27)

1. Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771, 2005.
2. Zhang B, Pan X, Cobb GP and Anderson TA: MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007.
3. Huppi K, Volfovsky N, Mackiewicz M, et al: MicroRNAs and genomic instability. Semin Cancer Biol 17: 65-73, 2007.
4. Kent OA and Mendell JT: A small piece in the cancer puzzle: MicroRNAs as tumor suppressors and oncogenes. Oncogene 25: 6188-6196, 2006.
5. Kumar MS, Lu J, Mercer KL, Golub TR and Jacks T: Impaired microrna processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677, 2007.
6. Warnasulasuriya S: Global epidemiology of oral and oropharyn-geal cancer. Oral Oncol 45: 309-316, 2009.
7. Gomes CC and Gomez RS: MicroRNA and oral cancer. Oral Oncol 44: 910-914, 2008.
8. Barnes L, Everson JW, Reichart P and Sidransky D: WHO -World Health Organization Classifcation of Tumours, Pathology and Genetics of head and neck tumours. Iarc Press, Lyon, p433, 2005.
9. Chen C, Ridzon DA, Broomer AJ, et al: Real-time quantifcation of micrornas by stem-loop rt-pcr. Nucleic acids res 33 1-9, 2005.
10. Livak KJ and Schimittgen T: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 25: 402-408, 2001.
11. Jiang J, Lee EJ, Gusev Y and Schimittgen TD: real-time expression profling of microRNA precursors in human cancer cell lines. Nucleic acids Res 33: 5394-5403, 2005.
12. Gaur A, Jewell DA, Liang Y, et al: Characterization of microrna expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468, 2007.
13. Calin GA, Dumitru CD, Shimizu M, et al: Frequent deletions and down-regulation of micro-rna genes mir15 and mir16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529, 2002.
14. Cimmino A, Calin GA, Fabbri M, et al: Mir-15 and mir-16 induce apoptosis by targeting Bcl2. Proc Natl acad Sci USA 102: 13944-13949, 2005.
15. Camisasca DR, Jonorato J, Bernardo V, et al: Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma. Oral Oncol 45: 225-233, 2009.
16. Ohigashi T, Ueno N, Novaka S, et al: Tyrosine kinase inhibitors reduce bcl-2 expression and induce apoptosis in androgen-dependent cells. Am J physiol cell Physiol 278: c66-c72, 2000.
17. Ogawara K, Miyakawa A, Shiba M, et al: Allelic loss of chromosome 13q14.3 in human oral cancer correlation with lymph node metastasis. Int J cancer 79: 312-317, 1998.
18. Takamizawa J, Konishi H, Yanagizawa K, et al: Reduced expression of the let-7 micrornas in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004.
19. Akao Y, Nakagawa Y and Naoe T: Let-7 microrna functions as a potential growth suppressor in human colon cancer cells. Biol pharm Bull 29: 903-906, 2006.
20. Childs G, Fazzari M, Kung G, et al: Low-level expression of micrornas let-7d and mir-205 are prognostic markers of head and neck squamous cell carcinoma. Am J pathol 174: 736-745, 2009.
21. Chang KW, Liu CJ, Chu TH, et al: Association between high mir-211 microrna expression and the poor prognosis of oral carcinoma. J Dent Res 87: 1063-1068, 2008.
22. Johnson SM, Grosshans H, Shingara J, et al: Ras is regulated by the let-7 microrna family. Cell 120: 635-647, 2005.
23. Christensen BC, Moyer BJ, Avissar M, et al: Let-7 microrna binging site polymorphism in the KraS 3'utr is associated with reduced survival in oral cancers. Carcinogenesis 30: 1003-1007, 2009.
24. Perez-Ordoñez B, Beauchemin M and Jordan RCK: Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 59: 445-453, 2006.
25. Hardisson D: Molecular pathogenesis of head and neck squamous cell carcinoma. Head Neck Oncol 260: 502-508, 2003.
26. Das BR and Nagpal JK: Understanding the biology of oral cancer. Med Sci Monit 8: 258-267, 2002.
27. Fukasawa K: Centrosome amplifcation, chromosome instability and cancer development. Cancer Lett 230: 6-19, 2005.